The Cell Therapy Catapult is entering into four commercial partnerships to further the development of regenerative therapies, as part of an Innovate UK collaborative R&D programme.
The catapult has announced that it will work with: Plasticell and the University of Oxford on a system to reproduce blood stem cells; with TAP Biosystems on a single-use reactor vessel; with Azellon, the University of Liverpool and NHS Blood and Transplant on a cell bandage; and with Athersys on a cell therapy for acute respiratory distress syndrome.
The collaborative projects are worth a combined £6.3 million and were the winning entries in a competition aimed at addressing challenges related to the preparation of regenerative therapies held by Innovate UK, formerly the Technology Strategy Board.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.